LivaNova PLC - Ordinary Shares (LIVN): Price and Financial Metrics
Today's Latest Price: $51.03 USD
Nov 23 4:00pm Add LIVN to Watchlist Sign Up
LIVN Stock Summary LIVN's went public 5.1 years ago, making it older than just 17.85% of listed US stocks we're tracking. With a year-over-year growth in debt of 79.66%, LivaNova PLC's debt growth rate surpasses 86.49% of about US stocks. Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for LIVN comes in at -15.85% -- higher than that of just 18.99% of stocks in our set. Stocks with similar financial metrics, market capitalization, and price volatility to LivaNova PLC are OPK, OSMT, SANW, DDD, and DHX. LIVN's SEC filings can be seen here. And to visit LivaNova PLC's official web site, go to www.livanova.com.
LIVN Price/Volume Stats
LivaNova PLC - Ordinary Shares (LIVN) Company Bio
LivaNova PLC. offers cardiac surgery, cardiac rhythm management, and neuromodulation related products worldwide. The company was founded in 1987 and is based in London, England.
LIVN Latest News Stream
All News Types
Acquisition Buyback Commentary Corp. News Earnings Guidance Up Mgmt Change New Coverage (Bullish) New Coverage (Neutral) Product News PT Lowered PT Raised Rating Reiterated (Bullish) Rating Reiterated (Neutral) Resumes Coverage (Bullish) Upgrade
Loading, please wait...
Latest LIVN News From Around the Web
Below are the latest news stories about LivaNova PLC that investors may wish to consider to help them evaluate LIVN as an investment opportunity.
Artificial heart-lung machine, commonly known as Artificial Cardiopulmonary Machine or cardiopulmonary bypass pump, is used to take the role of the heart and lungs during any cardiovascular surgical procedure. The Artificial Cardiopulmonary Machine Market report is an extensive, proficient and
LONDON--(BUSINESS WIRE)---- $LIVN--LivaNova PLC will host a conference call to discuss its third quarter 2020 results on Thursday, October 29, 2020 at 12 p.m. London (8 a.m. EDT).
LONDON--(BUSINESS WIRE)---- $LIVN--LivaNova PLC announced Damien McDonald, CEO, will present at the Baird 2020 Global Healthcare Conference on Thursday, Sept. 10 at 9:05 a.m. EDT.
LONDON--(BUSINESS WIRE)---- $LIVN--LivaNova poster at ESC 2020 to share potential for autonomic regulation therapy to improve heart failure patients' long-term cardiovascular function.
DUBLIN--(BUSINESS WIRE)--The "Neurology Devices Market 2019-2025" report has been added to ResearchAndMarkets.com's offering. The global neurology devices market is estimated to witness significant growth during the forecast period. Increasing demand for neurostimulation devices is one of the factors that are driving the market growth. Rising prevalence of neurological disorders, including Parkinson's and Alzheimer's disease has led the adoption of neurostimulation devices. In addition, rising
Read More 'LIVN' Stories Here
LIVN Price Returns
Get Free Updates
Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!
Page generated in 0.8928 seconds.